Here we studied whether glial cell line-derived neurotrophic factor (GDNF), given as a single bolus injection before an intrastriatal 6-hydroxydopamine (6-OHDA) lesion, can protect the nigrostriatal dopamine neurons against the toxin-induced damage and preserve normal motor functions in the lesioned animals. GDNF or vehicle was injected in the striatum (25 \ig), substantia nigra (25u.g) or lateral ventricle (50u.g) 6 h before the 6-OHDA lesion (20u.g/3uL). Motor function was evaluated by the stepping and drug-induced motor asymmetry tests. Lesioned animals given vehicle alone showed a clear ipsilateral-side bias in response to amphetamine (13 turns/min), a moderate contralateral-side bias to apomorphine (4.5 turns/min) and a moderate to severe stepping deficit on the contralateral forepaw (three to four steps, as compared with 1 1 -1 3 steps on the unimpaired side). Injection of GDNF into the striatum had a significant protective effect both on nigrostriatal function ( 1 -2 turns/min in the rotation tests and seven to eight steps in the stepping test), and the integrity of the nigrostriatal pathway, seen as a protection of both the cell bodies in the substantia nigra and the dopamine innervation in the striatum. Injection of GDNF in the nigra had a protective effect on the nigral cell bodies, but not the striatal innervation, and failed to provide any functional benefit. In contrast, intranigral GDNF had deleterious effects on both the striatal TH-positive fibre density and on drug-induced rotation tests. Intraventricular injection had no effect. We conclude that preservation of normal motor functions in the intrastriatal 6-OHDA lesion model requires protection of striatal terminal innervation, and that this can be achieved by intrastriatal, but not nigral or intraventricular, administration of GDNF.
Introduction
Parkinson's disease is a slowly progressive neurodegenerative disorder that affects specific neuronal populations in the central nervous system, most prominently the dopamine (DA) neurons of the substantia nigra (SN). Data obtained from postmortem analysis of brains from Parkinson's disease patients suggest that a significant portion of the nigral D A neurons still remain alive, albeit in an atrophic and compromised stage (Javoy-Agid etal, 1990; Fearaley & Lees, 1991; Schulzer etal, 1994) . The progressive nature of the degenerative process provides a basis for the development of neuroprotective therapies aimed at blocking or slowing down the .degenerative process, and stimulating recovery and regeneration of the remaining DA neurons. Intrastriatal injections of 6-hydroxydopamine (6-OHDA) provide a highly useful model of delayed and progressive neurodegeneration in the nigrostriatal DA system in rats. Administration of the toxin into the striatum, i.e. at the level of the axon terrninals, induces an acute terminal axotomy, followed by a protracted loss of the parent cell bodies within the SN that starts about 5-7 days after the lesion and progresses for several weeks after the insult (Sauer & Oertel, 1994; Przedborski etal, 1995) . This
Correspondence; Dr Deniz Kirik, as above. protracted time-course of degeneration thus provides a test bed for the efficacy of neuroprotective strategies. GDNF is one of the most potent neurotrophic factors for mesencephalic DA neurons identified so far. Previous studies have shown that GDNF can exert at least three different effects in the lesioned nigrostriatal D A system: (i) protection of the D A neurons against a toxic or mechanical insult; (ii) stimulation of axonal sprouting and regrowth from lesioned nigral D A neurons; and (iii) stimulation of D A turnover and function in those neurons which are spared by the lesion (for review see Björklund etal, 1997; Lapchak etal, 1997a; Gash etal, 1998) . The effects obtained in vivo depend on the time and site of administration of the trophic factor, as well as the type of lesion used. In the intrastriatal 6-OHDA lesion model, almost complete rescue of the nigral DA cell bodies can be obtained, not only when GDNF is given over the SN, but also when it is administered into the striatum or into the cerebrospinal fluid (Sauer etal, 1995; Winkler etal, 1996; Rosenblad etal, 1999; Rosenblad etal, 2000) . However, when administered after the toxic insult, GDNF does not preserve the D A innervation of the striatum and the functional impairments induced by the intrastriatal 6-OHDA lesion are only marginally affected, showing that preservation of the nigral cell bodies alone, in the absence of a functional striatal innervation, is not sufficient for behavioural recovery.
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The design of this study was aimed to identify the appropriate site and time of administration of GDNF to achieve preservation of the integrity of the nigrostriatal DA system in the intrastriatal 6-OHDA lesion model. We report that an intact nigrostriatal projection, and a functional striatal DA innervation, can be preserved when GDNF is administered as a single bolus injection 6 h before the 6-OHDA injection, and that this is obtained when the factor is delivered into the striatum, i.e. at the site of toxin injection, but not into SN or the lateral ventricle.
Materials and methods

Animals and surgical procedures
A total of 64 young female Spagué-Dawley rats (B&K Universal, Stockholm, Sweden) were housed four or five to a cage with free access to rat chow and water under a 1 2 : 1 2 h light-dark cycle. All surgical operations were performed according to rales set by the Ethical Committee for use of Laboratory Animals at Lund University.
Stereotaxic surgery was performed in two sessions using halothene anaesthesia. The animals were placed into stereotactic frames (Kopf Instruments, Tujunga, CA, USA). All injections were made using a 10-uL Hamilton microsyringe fitted with a glass pipette tip (outer diameter: 60-80 (im). All anteroposterior (AP) and mediolateral (ML) coordinates are calculated in millimetres from bregma and dorsoventral (DV) coordinates from the dural surface. A small burr hole was made at the calculated coordinates. At the position of the entry of the glass pipette, a small cut in the dura was made using a 28-gauge stainless steel injection cannula. This prevents the'glass pipette from bending and breaking during penetration. The injection rate was 1 uL/ min and the glass pipette was left in place for an additional 2 m i n before it was slowly retracted.
In the first surgery session, the animals received either GDNF or' vehicle solution (saline) into one of the following locations (all on the right side):
1. the SN-GDNF group received a supranigral injection of 25 jig/ 21¡L GDNF (n = 18) or vehicle solution (n = 8) at AP: -5 . 3 , ML: -2.0, DV: -6 . 2 , incisor bar set at -2 . 3 ; 2. the STR-GDNF group received an intrastriatal injection of 2 5 | i g / 2 u L GDNF (/i =18) or vehicle solution (n = 7) at AP:+1.0, ML: -3 . 0 , DV: -5 . 0 , incisor bar set at 0.0; and 3. the ICV-GDNF group received an intracerebroventricular injection of 5 0 u g / 4 u L GDNF ( n = 10) or vehicle solution (/z = 3) at AP: 0.0, ML: -1 . 2 , DV: -3 . 5 , incisor bar set at -3 . 3 .
After the injection of the GDNF, the animals were allowed to recover from the anaesthesia and returned to their home cages until the second surgery. Six hours after the initial surgery, all animals received a unilateral injection of 20p.g/3(xL of 6-OHDA (Sigma, St Louis, MO, USA; calculated as free base, dissolved in ice-cold saline with 0.02% ascorbic acid) in the right striatum at AP: +1.0, ML: -3.0, DV: -5 . 0 , the incisor bar set at 0.0. The toxin solution was kept on ice, used fresh and protected from light to minimize oxidation.
A total of 16 animals from the SN-GDNF and the STR-GDNF groups and eight animals from the SN and STR vehicle injections were sacrificed at 1 and 7 days after the lesion for evaluation of the distribution of GDNF immunoreactivity (GDNF-IR) and retrograde degeneration of the nigrostriatal fibres. Remaining vehicle-treated animals (n = 10) were pooled together as a combined control group.
Behavioural analysis
The sequence of behavioural testing in the 6-week survival group is summarized in Fig. 1 .
Rotational behaviour
At 4, 5 and 6 weeks after the lesion, drug-induced rotational behaviour was monitored in automated rotometer bowls (Ungerstedt & Arbuthnott, 1970) . At each interval, the animals were injected with apomorphine (Research Biochemicals Incorporated, St Louis, M O , USA; 0.25mg/kg s.c.) and motor asymmetry was monitored for 40 min. Three days after the apomorphine test, amphetamine (Apoteksbolaget, Sweden; 2.5 mg/kg i.p.) was injected and the animals were monitored for 90 min. Net rotational asymmetry score is expressed as full body tums/min. Direction ipsilateral to the side of lesion is given a positive value.
Stepping test
During the third and sixth weeks after lesion, the animals were tested for forelimb akinesia in the stepping test, as described by Olsson etal. (1995) . This test is a modification of the so-called bracing test introduced by Schallert etal. (1992) . On the day before the test, the ; animals were handled by the experimenter in order to familiarize '• them with the test procedure. The test was performed twice daily on 3 -' • consecutive days. Briefly, the rat was held by the experimenter fixing its bindlimbs with one hand and the forelimb not to be monitored with the other, while the unrestrained forepaw was touching the table. The number of adjusting steps was counted while the rat was moved sideways along the table surface (90 cm in 5 s), in the forehand direction (i.e. the animal was moved to left when right paw was unrestrained), for both forelimbs.
Histology
Perfusion and tissue processing
The animals were deeply anaesthetized with pentobarbital and perfused through the ascending aorta with 50 mL of isotonic saline, ; followed by 250 mL of 4 % paraformaldehyde in 0 . 1 M phosphate buffer (PB; pH7.4). Brains were postfixed for 2 h in the same solution , and cryoprotected in 2 0 % sucrose in 0.1 M PB. In the 1-and 7-day . survival groups, the brains were cut in three series in the oblique horizontal axis. The brains from the 6-week survival groups were cut in five series of 40-um thick coronal sections on a freezing microtome.
hnmunohistochemical stainings
For all stainings the sections were rinsed three times in potassium phosphate buffer (KPBS) between each incubation period. All ; incubation solutions contained 0.25% Triton X-100 in KPBS. The sections were quenched for 10 min in 3 % H 2 O 2 / 1 0 % methanol in ; KPBS. For tyrosine hydroxylase (TH) immunohistochemistry, the sections were precoated with 5% normal horse serum (NHS) and incubated overnight at room temperature with 1:2000 dilution of , mouse anti-TH antibody (Chemicon Inc., Temecula, CA, USA) in 2% NHS. This was followed by incubation with 1:200 dilution of biorinylated horse antimouse antibody (BA2001, Vector ', Laboratories, Burlingame, CA, USA) in 2 % NHS. For GDNT iinmunohistochernistry, the sections were precoated with 5% NIKS, then incubated overnight at room temperature with 1:2000 dilution . of goat anti-GDNF antibody (R&D systems, Minneapolis, MN, USA) in 2 % NHS. This was followed by incubation with 1:200 dilution of , biorinylated horse antigoat antibody (BA9500, Vector Laboratories) in 2 % NHS. In both stainings, the reaction was visualized with avidin biotin peroxidase complex (ABC-Elite, Vector Laboratories), using . 3,3-diaminobenzidine as a chromogen. Sections were mounted on chrome alum-coated slides, dehydrated in ascending alcohol concentrations, cleared in xylene and coverslipped in DEPI'-X mounting medium. Stepping test was performed in two sessions (step I-H) during the fourth and sixth weeks posdesion. Turning behaviour induced by either apomorphine (0.25 mg/kg) or d-amphetamine (2.5 mg/kg) was monitored at 4, 5 and 6 weeks posdesion (apo I-HI and amph I-ITJ). After completion of the behavioural tests, the animals were killed and the brains were processed for immunohistochemistry, as described in the Methods section. Two separate groups of animals were killed at 1 and 7 days posdesion for evaluation of TH-positive fibre die-back and distribution of GDNF protein.
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Morphological analysis
SN ceil counts
The unbiased stereological estimation of the total number of the cells in SN was made using the optical fractionator principle. This sampling technique is not affected by tissue volume changes and does not require reference volume determinations (West etal, 1991) . The borders of the SN at all levels in the rostrocaudal axis were defined. The medial border was defined by a vertical line passing through the medial tip of the cerebral peduncle (and by the medial terminal nucleus of the accessory nucleus of the optic tract, when present in the sections), thereby excluding the TH-positive cells in the ventral tegmental area (VTA). Ventral border followed the dorsal border of the cerebral peduncle, thereby including the TH-positive cells in pars reticulata, and the area extended laterally to include the pars lateralis in addition to pars compacta. The sections used for counting covered the entire SN from the rostral tip of the pars compacta back to the caudal end of the pars reticulata. This yielded between nine and 11 sections in a series.
Sampling was done using the Olympus CAST-Grid system (Olympus, Denmark). The system is composed of an Olympus BH2 microscope, an X-Y step motor stage run by a IBM-compatible PC computer, and a microcator (Heidenhain, ND 281, Traunreut, Germany). The CAST-Grid software (version 1.10) was used to delineate the SN at 4X objective and generate counting areas of 2 5 0 X 2 5 0 u n r . A counting frame (5445 urn 2 ) was placed randomly on the first counting area and systematically moved through all counting areas until the entire delineated area was sampled. Actual counting was performed using a 100X oil objective (with numerical aperture 1.4). Guard volumes (5 a m from the top and 5-8 um from the bottom of the section) were excluded from both surfaces to avoid the problem of lost caps, and only the profiles that came into focus within the counting volume (with a depth of 10 urn) were counted. The estimate of the total number of neurons was calculated according to the optical fractionator formula (for more details see West etal., 1991) .
Striatal fibre density measurements
The optical densities of the TH-positive fibres in the striatum were measured using the NTH 1.62 Image program on a Macintosh 9500 computer connected to a digital camera (Contron ProgRes 3012, Kontron Elektronik GmBH, Germany) and a constant illumination table. For each animal, the optical density was measured at 7 rostrocaudal levels according to the atlas of Paxinos & Watson (1998) over the whole striatum: (1) AP: +1.6; (2) AP: +1.0; (3) AP: +0.2; (4) -0-3; (5) AP: -0 . 9 ; (6) AP: -1 . 4 ; and (7) AP: --l m m relative to bregma. To estimate the specific TH staining density, the optical density readings were corrected for nonspecific background density, as measured from the completely denervated parts of the striatum. The data is presented as a percentage of the intact side.
Statistical analysis
Between-group comparisons for all behavioural and morphological measures were performed using ANOVA. Repeated-measure ANOVA was used for behavioural tests and two-way ANOVA was used for comparison of optical density measurements. Where the ANOVA showed significance, post hoc analysis was done using the Student's Newman-Keuls test. The correlation between the behavioural and morphological measures was calculated using simple regression analysis on the log-transformed data.
Results
The protective effect of GDNF, given either over the SN (25 ug), into the striatum (25 ug) or into the lateral ventricle (50 ug) 6 h before the intrastriatal 6-OHDA lesion, was investigated by morphological analysis (nigral cell loss and damage to the nigrostriatal projection) and in a battery of behavioural tests. Behavioural impairments were assessed at 3-6 weeks and the brains were processed for TH immunohistochemistry at 6 weeks postlesion (Fig. 1) .
Survival of nigral DA neurons
In the lesioned animals given vehicle alone, 30% of the TH-positive cell bodies in the SN remained intact by 6 weeks postlesion (Fig. 2 ). GDNF administered either over the SN or in the striatum had a significant protective effect on the lesioned nigral TH-positive cells. The protective effect was significantly better in the STR-GDNF group where over 85% of the TH-positive cells survived by the end of the experiment, compared with about 60% in the SN-GDNF group (see inset in Fig. 2 ). Intraventricular GDNF injection, although at a twofold higher dose, was ineffective (65% cell loss).
Sparing of the nigrostriatal DA projection
Inspection of coronal sections from different rostrocaudal levels through the nigrostriatal pathway revealed a marked loss of THpositive innervation in the striatum in the vehicle group. Similar to what has been described previously in this model (Sauer & Oertel, 1994; Kirik etal., 1998) , the denervation was most prominent in the dorsolateral aspect of the head of the caudate putamen ( Fig. 3B ), but extended also into the caudal tail ( Fig. 4B) . At the level of the globus pallidus (GP; Fig. 4B ) and medial forebrain bundle (MFB, Fig. 5B ), the amount of TH-positive fibres was also greatly reduced. In the STR-GDNF group, significant sparing of the TH-positive innervation . While a single dose of GDNF injected intrastriatally gave almost complete protection (D), injection of GDNF in the SN was only partially effective (C), and injection into the lateral ventricle had no protective effect (E). Quantification of TH-positive cell numbers in the SN (inset) was estimated using stereological counting methods, as described in Methods. *P<0.001, different from all other groups, t ? < 0 . 0 1 , different from vehicle and ICV-GDNF groups, ANOVA ^3.36 = 33.74 followed by Student's Newman-Keuls test. Scale bar in A, 500 um.
was seen in the dorsolateral striatum (Fig. 3D , and inset), and the TH-• positive axons along the nigrostriatal pathway, in the MFB (Fig. 5D ) and-GP (Fig.4D) were similar in appearance to those on the intact side. In addition, a dense fibre network of thin varicose irregular fibres with the appearance of sprouting fibres, was seen (marked by arrowhead in Fig. 4D ). The extent of terminal sparing varied among the animals in the STR-GDNF group. In six of the 10 animals there was a near-complete sparing and/or regeneration of the striatal THpositive fibres (Fig. 3D) , whereas in two animals the extent of the denervation was similar to that seen in the vehicle-treated animals.
In the SN-GDNF group, the density of the remaining striatal THpositive innervation was less than that of the vehicle-treated animals (Fig. 4C , see inset in Fig. 3 ). Very few TH-positive fibres were seen in the GP (Fig. 4C ) and further caudally along the nigrostriatal pathway (Fig. 5C ), indicating that supranigral GDNF was not able to prevent the lesion-induced dieback of the nigrostriatal DA axons. However, a prominent fibre network of thin irregular fibres extending about 2 mm rostrocaudally and 1-2 mm dorsoventrally from the injection site was seen dorsal to the SN (Fig. 6 ), indicating that sprouting was elicited locally at the site of GDNF administration. The ICV-GDNF group was indistinguishable from the vehicle group at all levels through the nigrostriatal pathway (Figs 3E, 4E and 5E) .
Quantification of the TH-positive innervation of the striatum by optical density readings from seven equally spaced rostrocaudal levels (inset in Fig. 3) showed that, on average, 40% of the striatal innervation remained in the vehicle group. The STR-GDNF group had significantly more TH-positive fibres (60-80% at different levels), and the SN-GDNF group significantly less than the vehicle group. In the vehicle, SN-GDNF and ICV-GDNF groups, the density of TH-positive fibres in the GP was markedly reduced compared with the intact side (inset in Fig. 4 ). In the STR-GDNF group, by contrast, the density of TH-positive fibres in GP was significantly increased above that seen on the intact side (180%).
In order to evaluate the extent of retrograde degeneration of the DA projection fibres, we analysed the nigrostriatal pathway in THimmunostained sections from a separate group of animals that were sacrificed 1-week postlesion (Fig. 7) . Figure 7A illustrates in a horizontal section (slightly tilted to match the plane of the bundle) the intact TH-positive projection passing through the GP and innervating the striatum. In the vehicle group, the 6-OHDA lesion resulted in loss of terminal innervation in a wide area of the caudate putamen, extending 3-4 mm around the injection site (asterisk in Fig. 7B) , and a retraction of the TH-positive axons in the nigrostriatal pathway caudally, down to a level close to the SN (arrows in Fig. 7B ). We observed two types of responses in the STR-GDNF group ( Fig. 7C and D) . In two of the animals, the area of denervation in te striatum was greatly reduced, and there was a local increase of THpositive fibres in adjacent areas of GP caudal to the striatum (Fig. 7C) . In the second type of response, seen in two other animals in this group, the loss of innervation in the striatum was more extensive and associated with a more prominent and wide-spread increase of TH-positive fibres in the central and caudal parts of the GP and the internal capsule (Fig. 7D) .
Assessment of motor function
At 3 and 6 weeks postlesion, motor behaviour was assessed using both the stepping test and drug-induced (amphetamine and apomorphine) rotation (Fig. 8) . In the stepping test all animals performed 11-13 steps with the unimpaired ipsilateral paw (Fig. 8A) . There was no protection of THPositive fibres in either the SN-GDNF (C) or in the ICV-GDNF (E) groups. By contrast, in the STR-GDNF group, TH-positive fibre innervation was protected to a ge extent (D). Optical density of TH-positive fibres in the striatum was measured at 7 rostrocaudal levels, as shown in the inset. In the vehicle-treated lesion controls, optical density was reduced by 60-70% (compared with the intact side) in the anterior and central parts of the striatum (levels 1-4) and by 40-50% in the ateral and caudal parts (levels 5-7). The STR-GDNF group had higher optical TH-positive fibre density values compared with all other groups. By contrast, the j^GDNF group had overall lower optical density values than the vehicle control. The ICV-GDNF group did not differ from the vehicle group. *P< 0.001 "uterent from all other groups, i\P<0.01 different from vehicle; ANOVA F3,252 = 34.55 followed by Student's Newman-Keuls test. Scale bar in A, 500um. A and B) . Note the more extensive striatal denervation in the SN-GDNF group (C). In the STR-GDNF group, density of the terminal innervation in lateral striatum was close to normal and the fibres in the GP were preserved (D). ICV-GDNF did not have any protective effect in GP or in the lateral striatum fE). Also, note the sprouting of TH-positive fibres in the GP in the STR-GDNF group (arrowhead in D). Optical density of TH-positive fibres in GP was measured at level 5 (see schematic drawing in Fig. 3) . The 6-OHDA lesion caused about a 709t reduction in optical density in GP compared with the intact side. The STR-GDNF group had increased TH-positive fibres ipsilateral to the lesion, reaching 180% of the intact value. The SN-GDNF and ICV-GDNF groups were not different from the vehicle group. *P< 0.001 different from all other groups; ANOVA F 3t36 = 65.76 followed by Student's Newman-Keuls test. Scale bar in A, 500 um. CC: corpus callosum, CPU: caudatus putamen, GP: globus pallidus.
contralateral paw in the vehicle group (average three to four steps). Neither the SN-GDNF, nor the ICV-GDNF groups differed from the vehicle group at any time point. However, the animals in the STR-GDNF group made significantly more steps than those of the other treatment groups (seven to eight steps) at both 3 and 6 weeks postlesion, and six of 10 animals had regained normal performance in the test (> 10 steps). These six animals were the ones that exhibited the most complete sparing of the TH-positive innervation in the striatum (discussed previously). Three of the remaining animals were significantly impaired and made two to five steps. These three animals had a more extensive loss of TH-positive innervation in the striatum.
Injection of amphetamine elicited a strong ipsilateral turning response (10-16 turns/min) in the vehicle group in all three test sessions (Fig-8B) . The ICV-GDNF group did not differ from controls at any time point. In the SN-GDNF group, the turning response was similar to vehicle controls at 4 weeks, but significantly increased at 5 and 6 weeks. The STR-GDNF group, by contrast, showed only a very mild bias (3.5 turns/min) at 4 weeks, and this was further reduced at 5 and 6 weeks postlesion. In the apomorphine test (Fig. 8C) , the turning response increased with repeated testing, from 2.3 rnrns/min in the first test (at 4 weeks postlesion) to 4.9 turns/min in the third test (at 6 weeks) in the vehicle group. The ICV-GDNF group did not differ from the vehicle group at any time point, whereas the turning in il vehicle group at the second and the third tests. The animals that received vehicle injections in the SN did not show increased rotation compared with the vehicle injections to other sites, suggesting that the deleterious effects observed in the SN-GDNF group were specific to GDNF treatment.
Correlation of morphological and behavioural parameters
As summarized in Table 1 , TH-positive cell numbers in SN (expressed as percentage of control side) were poorly correlated overall with all other measures ( r < 0 . 5 ) . In contrast, striatal THpositive optical fibre density showed good correlation with the rats' Performance in both the stepping test and the amphetamine and a Pomorphine rotation tests ( r > 0 . 7 ) . The performance in the three behavioural tests was well correlated with each other (r>0.65). It is notable that the TH-positive fibre density in the striatum was not well correlated with the number of TH-positive cells in SN, which' is readily explained by the differential rescue of cell bodies and terminals in the SN-GDNF group.
Distribution of GDNF-IR after a single bolus injection
The distribution of the injected GDNF was assessed by immunohistochemistry at 1 and 7 days after intrastriatal or supranigral GDNF injection (Fig. 9) . One day after intrastriatal injection, GDNF-IR was distributed over the whole ipsilateral cerebral hemisphere extending all the way down to the midbrain ( Fig. 9A ; illustrated in an oblique horizontal section, similar to Fig. 7) . At this time point, the protein was mainly localized extracellularly. By 7 days, the GDNF protein was still detectable in the ipsilateral hemisphere (Fig. 9B) 
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FIG. 7. Extent of 6-OHDA-induced denervation and GDNF-induced sprouting at 7 days postlesion, as observed in oblique horizontal sections stained with antibody against TH. Normal appearance of the intact system is shown in A. In the vehicle group, the majority of the TH-positive fibres had already degenerated by 7 days postlesion (B) and the fibres of the nigrostriatal pathway had retracted back to a level close to SN (arrows in B). In the STR-GDNF group, we observed two types of responses (C and D). In some of the animals the TH innervation of the caudate putamen (CPU) appeared normal (C) except for a small lesion core (* in C) and an increase in TH-positive fibres in the GP just caudal to the denervated area. In (D), the denervation in the striatum was larger and the increase in the TH-positive fibres was more intense and located more caudally in GP and the internal capsule (IC). Asterisks mark the location of the 6-OHDA injection. Scale bar in A, 500 um. LV: lateral ventricle, CC: corpus callosum.
time point, however, the GDNF-IR was mainly confined to the striatum and GP. In addition to the extracellular staining, GDNF-IR was visualized also in fibres that extended caudally along the white matter tracts (Fig. 9C) . After the supranigral injection, GDNF-IR was widely distributed in the midbrain and also seen in the ventral hippocampus by 1 day. Striatum and GP were clearly devoid of any immunoreactivity (Fig. 9D ). Seven days after injection, GDNF-IR was more restricted and mainly confined to the ventral midbrain, adjacent caudal thalamic areas and the ventral hippocampus (Fig-9E) . At both time points, the whole extent of the SN was seen to contain GDNF unmunostaining. Neuron-like GDNF-IR profiles were clearly visible within the midbrain (Fig. 9F ).
Discussion
The present experiment was designed to assess the ability of exogenous GDNF to preserve the integrity of the nigrostriatal DA system (i.e. cell bodies, axons and axon terminals) and normal motor function, when administered as a single dose of 25-50 |ig in the striatum, substantia nigra or lateral ventricle 6 h before an intrastriatal 6-OHDA lesion. We found that the neuroprotective effects of GDNF were greatly dependent on the site of administration, and that the neurotrophic actions of the factor may be mediated by at least three distinct mechanisms: (i) acute protection against the lesion; (ii) delayed rescue of cell bodies; and (iii) sprouting and regrowth from injured axons.
Acute protective effect at the site of toxin injection
In a previous study, Keams etal. (1997) showed that optimal protection of nigral TH-positive cell bodies against an intranigral 6-OHDA injection is obtained when GDNF (injected at the same site in a single dose of 10 ug) is given 6 h prior to the lesion. Using the same time interval between the GDNF and the 6-OHDA injections, we observed here a prominent protective effect on the TH-positive axon terminals in the striatum against an intrastriatal injection of the toxin, but only when GDNF was injected into the striatum, i.e. at the same site as the 6-OHDA injection. By contrast, administration of GDNF at the level of the cell bodies in the SN, had a significant effect on the survival of DA cell bodies in the nigra but did not afford any protection of the terminals in the striatum. Similarly, ICV-GDNF injection had no effect. The site dependence of the GDNF-induced effect suggests a local action, since the protective effect is seen only when both the GDNF and the toxin are injected at the same site (i.e. SN in the Kearns etal., 1997 study, and striatum in the present experiment). Although the exact mechanism of this local protective action is unknown, it is conceivable that it may involve either blockade of transport of 6-OHDA across the axonal membrane via the DA transporters, or an increased efficiency in the intracellular detoxification of internalized 6-OHDA via antioxidant mechanisms. Data from the Kearns etal. (1997) study suggest that an intracellular process, possibly involving protein synthesis, is necessary for this acute protective action. However, given the short time interval (6h) between the GDNF and 6-OHDA administrations, it seems unlikely from the data presented in this study that this local protective effect of GDNF is a process that involves the cell body, e.g. by induction of de novo synthesis of proteins that are subsequently transported to the terminals in the striatum.
Administration of GDNF by the intraventricular route was, ineffective in the present study. This indicates that the diffusion of GDNF protein into the striatum or SN at the present dose (50 ug) was insufficient to produce GDNF tissue levels necessary to provide any protective effect against the subsequent 6-OHDA injection. This is consistent with the autoradiographic data of Lapchak etal. (1997b) , showing very limited penetration of radiolabelled GDNF into the striatum from the cerebrospinal fluid. In agreement with these findings, Kobayashi etal. (1998) have studied the distribution of GDNF after ICV injections (10 ug) using irnmunohistochemistry, where they have seen relatively poor penetration of GDNF into the brain parenchyma after ICV injections compared with the intrastriatal delivery. In addition the authors also reported that very few nigral neurons were seen to contain GDNF-IR after ICV injections. Nevertheless, higher doses of GDNF (100-1000 ug) given ICV have been reported to induce behavioural and biochemical effects in 6~ OHDA-lesioned rats (Bowenkamp etal., 1997; Lapchak etal, 1997c) Stepping test was performed during the fourth and sixth weeks postlesion (A). At both time points, forelimb performance was similar in all groups (11-13 steps, open symbols). In the vehicle group, the 6-OHDA lesion induced severe impairment in forelimb stepping on the side contralateral to the lesion. The STR-GDNF group performed better than all other groups, while the SN-GDNF and ICV-GDNF groups were as impaired as the vehicle controls. *P<0.001, different from all others; ANOVA ^3 6 = 5 . 1 2 followed by Student's Newman-Keuls test. D-amphetamine-(2.5 mg/kg) induced rotation was monitored at 4,5 and 6 weeks postlesion (B). The vehicle group showed a clear ipsilateralside bias. This motor asymmetry was almost completely abolished in the STR-GDNF group, but further accentuated in the SN-GDNF group at weeks 5 and 6. The ICV-GDNF group was not different from the vehicle group at any time point *P< 0.001 different from all other groups, tP<0.01 different from all other groups; ANOVA F 3 3 6 = 12.35 followed by Student's Newman-Keuls test. Apomorphine-(0.25mg/kg) induced rotation was monitored 3days before each amphetamineinduced rotadon test (C). The vehicle group showed a moderate turning response that further increased in the two subsequent tests. This turning bias was completely blocked in the STR-GDNF group, further increased in the SN-GDNF group and unchanged in the ICV-GDNF group. *P<0.05 different from a n others; ANOVA F 3 i 3 6 = 4 . 6 2 followed by Student's Newman-Keuls test. and in MPTP-lesioned monkeys (Gash etal., 1996) which appears to be due to limited diffusion of the protein into the ventral mesencephalon (SN and VTA). This is further supported by the results of Rosenblad etal. (1999) , showing that repeated injections of GDNF intraventricularly can afford effective neuroprotection of iMioned DA neurons in SN when administered every third day during the first 3 weeks (7 X 10 ug) after an intrastriatal 6-OHDA lesion.
Rescue of injured DA neurons
Intranigral injection of GDNF did not block the acute toxic damage of •he axon tenninals in the striatum in the SN-GDNF group, while the flayed degeneration of the cell bodies of the axotomized DA neurons in. the SN was partially prevented. The intrastriatal GDNF "'lection, by contrast, provided not only an acute protection of the s t t i atal terminals in the STR-GDNF group, but also a near-complete ft-Kuie of the axotomized DA neurons. Clearly, single injections of ' *F in the SN give only partial protection of the cell bodies in the intrastriatal 6-OHDA lesion model, when given either before (Keams & Gash, 1995; this study) or during the first week after the lesion (Sauer etal., 1995; Horger etal., 1998) .
In the intranigral lesion model, Kearns etal. (1997) and Sullivan etal. (1998) have reported almost complete rescue of the TH-positive cells in the SN, and also a partial protection of the striatal TH-positive innervation, by a single intranigral injection of GDNF given shortly before the lesion. In these cases, however, both GDNF and 6-OHDA were administered in or close to the SN. The more pronounced neuroprotective effect of intranigral GDNF in these studies are readily explained by two factors. First, in ffiere^xperiments the rescue of THpositive cells represents an acute protective effect of GDNF, as discussed previously, as opposed to the rescue from delayed cell death of axotomized neurons seen in the intrastriatal lesion model. Second, in the intranigral 6-OHDA lesion model, the direct action of the toxin on the DA cell bodies leads to cell death within hours (Ungerstedt, 1971) . A single bolus injection of GDNF close to the cell bodies during 
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R G . 9. GDNF immunoreactivity observed in oblique horizontal sections at 1 (A and D) and 7 days (B, C, E and F) after a single injection of 2 5 ug GDNF in striatum (A-C) or SN (D-F). One day after the intrastriatal administration, the protein was distributed over the entire striatum and extended into the overlying cortex and caudally into the GP and internal capsule (A). Note the diffuse, mostly extracellular localization of the protein at this time point. However, at 7 days postinjection, the GDNF protein was mainly confined to striatum and GP (B). GDNF-positive fibres were seen to extend caudally in the white matter tracts of the internal capsule (arrowhead in B , enlarged in C). One day after intranigral injection, the GDNF protein was distributed widely within the midbrain (including SN) and was also seen in the ventral hippocampus (D). At 7 days postinjection, the GDNF immunoreactivity was mainly found around the SN and adjacent structures. The GDNF protein in the ventral hippocampus persisted at this time point (E). Within and adjacent to SN, there were cellular profiles immunoreactive for GDNF (arrowhead in E , enlarged in F). No GDNF immunoreactivity was detected in the striatum or GP in the SN-GDNF group either at 1 (D) or 7 days (E).
or preceding this critical time period may result in near-complete rescue of the cell bodies. In the intrastriatal 6-OHDA lesion model, the TH-positive cell death is delayed, starting about 1 week after the initial damage and continuing for several weeks thereafter (Sauer & Oertel, 1994) . This protracted cell death probably results in death of different subpopulations of cells at different time points after the lesion. For this reason, it is likely that GDNF, when administered in the SN, has to be present, over a longer time period in order to provide optimal neuroprotection. Indeed, continuous delivery of GDNF over the SN during the first 2 -3 weeks postlesion has been shown to provide complete (85-95%) rescue of the cell bodies of the axotomized nigral DA neurons in the intrastriatal lesion model (Sauer etal., 1995; Lu & Hagg, 1997; Rosenblad etal, 2000) .
Regeneration of axons from spared DA neurons
A third mode of action of GDNF is the stimulation of axonal sprouting and regrowth from the severed axons of injured DA neurons. We have previously reported sprouting of TH-positive fibres in the GP (Rosenblad etal, 1999) or striatum (Rosenblad etal, 1998) after repeated injections of GDNF in the striatum, starting l d a y or 4 weeks after the 6-OHDA lesion, respectively. Local sprouting of TH-positive fibres after GDNF injections over the SN have also been observed previously (Bowenkamp etal, 1995; Winkler etal, 1996; Tseng etal, 1997) . Figure 10 illustrates schematically the localization and extent of axonal sprouting induced by a single injection of GDNF in the SN-GDNF and the STR-GDNF groups. In the vehicle-treated animals (Fig. 10A) , retrograde degeneration of the fibres and cell bodies takes place during the first few weeks following the lesion. A single injection of GDNF into the striatum was sufficient to induce extensive sprouting, primarily in the GP (Fig. 10B) . The intrinsic TH-positive fibres passing through GP were preserved and there was a network of thin-calibre, TH-positive fibres with highest density in the medial parts of the GP. In the SN-GDNF group (Fig. IOC) , sprouting of TH-positive fibres was documented around the injection site of GDNF, extending dorsally as a fine network of thin fibres, reaching into the ventral thalamus. The distribution of the newly formed TH-positive fibres in the STR-GDNF and SN-GDNF groups occurred in the area of high levels of GDNF (as seen in the immunostained sections). This strongly suggests that sprouting is induced from surviving intact or lesioned axons in the area reached by high concentrations of the injected GDNF protein. or GDNF (B and C) adrninistration 6 h prior to the intrastriatal 6-OHDA lesion. The 6-OHDA lesion induces destruction of axon terminals in the striatum surrounding the injection site. This leads to retrograde degeneration of the axons which is followed by a delayed death of the DA neurons in the SN. Part A represents the status of nigrostriatal projection at 6 weeks posdesion, i.e. at a time point when the fibre degeneration is complete and most of the cell death has taken place. Intrastriatal administration of GDNF (B) protects against the initial direct destruction of the axon terminals and hence protracted cell death in the SN. In addition to the direct protective effects, intrastriatal GDNF also causes sprouting of TH-positive fibres locally in the GP and striatum within the area reached by the GDNF protein (grey circles). Administration of GDNF in the SN (C) is sufficient to protect the cell bodies, but does not preserve the axons or the terminals in the striatum. In this case, sprouting is prominently close to the SN, i.e. in the area of high GDNF concentration.
Preservation of motor function in the 6-OHDA-lesioned rats
Although both intranigral and intrastriatal GDNF preserved the nigral neurons, only the intrastriatal route was efficient in preserving motor functions in the lesioned animals. The microscopic data indicate that the functional benefit in the STR-GDNF group was due to the preservation of a significant portion of the nigrostriatal projection and sparing of the dopamine innervation of the striatum, possibly in combination with GDNF-induced sprouting of spared TH-positive axons in the lesioned striatum. Consistent with this, we observed an overall strong correlation between the striatal TH-positive fibre innervation among the animals in the four treatment groups and their performance in the three behavioural tests.
The most prominent sprouting response in the STR-GDNF group was seen in the GP and along the internal capsule. Whether this sprouting response has any functional effects remains unclear. From our earlier work (Rosenblad etal., 1999 (Rosenblad etal., , 2000 , it seems that THpositive fibre sprouting in GP alone is ineffective in promoting any functional recovery in this model. On the other hand, the fact that extensive sprouting in GP occurred in animals that showed close to normal motor behaviour would argue against any overt negative functional effects of this sprouting response. ; Interestingly, in the SN-GDNF group, the TH-positive fibre density m the striatum was significantly reduced compared with the vehicletreated controls, suggesting that administration of GDNF over the mgra may block (rather than promote) regeneration in the striatum. Induction of aberrant local sprouting close to the SN, as illustrated in Fig-IOC , may have contributed to this effect. Indeed, the combination of impaired re-innervation of the striatum and aberrant sprouting in the ventral thalamus may explain why motor impairments were more severe in the SN-GDNF group compared with the vehicle-treated controls.
h a recent study, Connor etal. (1999) addressed the site ependence of GDNF delivery, using injections of an adenovirus-GDNF vector into either striatum or SN in 6-OHDA-lesioned, old rats. Although the lesion-induced impairments were small with the type of lesion used, significant functional sparing was observed in the striatal group, while amphetamine-induced rotation was more pronounced in the SN-injected group than in thé lesioned controls. However, no sprouting response was observed which may be due to the size of 6-OHDA lesion and the lower amount of GDNF delivered by the vector.
Conclusions
These findings provide the first direct demonstration that survival of nigral D A neurons and preservation and/or regeneration of a functional striatal DA innervation are distinctly regulated in the intrastriatal 6-OHDA lesion model, and that the ability of exogenously administered GDNF to induce these two types of effects depends on the site of administration of the trophic factor. Preservation of a functional nigrostriatal D A projection is possible in the intrastriatal 6-OHDA lesion model when GDNF is administered in the striatum (i.e. the site of toxin injection) but not in the SN, provided that the factor is given prior to the toxic insult. Rescue of DA neurons in SN alone, in the absence of a functional striatal innervation, is insufficient for preservation and/or recovery of striatal motor functions. In Parkinson's disease, it seems possible that the progressive degeneration of the nigrostriatal D A neurons is the result of an insult that acts primarily on the terminals in the striatum (Fearnley & Lees, 1991; Gibb & Lees, 1994) . If so, the present findings indicate that this process may be efficiently halted by delivery of GDNF in the striatum. Intranigral delivery, on the other hand, may be a relevant strategy if the primary pathology is intrinsic to the nigral D A neurons. However, the induction of aberrant sprouting, if functionally detrimental, may be a concern when GDNF is administered at the level of the SN.
